Jinan Yongxin New Material Technology Co., Ltd. purchased MicroInstrument Optoelectronics V1800-2000M for sterility testing of nonwoven fabric fibers

Views: 0

Jinan Yongxin New Material Technology Co., Ltd. purchased Micro Instrument's Optoelectronic Trinocular Biological Microscope V1800-2000M for sterility testing of nonwoven fabric fibers. Features of our Trinocular Biological Microscope V1800:

1. Uses high-brightness, adjustable color temperature LED lamps for long lifespan, easy maintenance, and outstanding quality.

2. Equipped with a 23mm ultra-wide field eyepiece and an infinity flat field achromatic objective, providing a flat field of view.

3. Equipped with ECO energy-saving mode and infrared sensor automatic power-off function, energy-saving and safe.

4. Uses an external transformer for safe voltage input and supports USB output power supply.

5. Equipped with Kensington lock slots for easy display and use in public environments, preventing loss.

6. The entire machine is treated for mold resistance, effectively protecting the lens and extending the instrument's service life.

 

 Jinan Yongxin New Material Technology Co., Ltd. purchased MicroInstrument Optoelectronics V1800-2000M for sterility testing of nonwoven fabric fibers

Jinan Yongxin New Material Technology Co., Ltd. (hereinafter referred to as Yongxin Technology) was established in June 2017. In terms of product application, Yongxin Technology will not only strengthen its main markets in wet wipes, wipes, and facial masks, but also vigorously develop new biomass fiber raw material products and technologies, and develop high value-added, functional, and differentiated series of products. Spunlace fabric made from biomass, natural, eco-friendly, and functional raw materials such as camellia fiber, mint fiber, and chitosan fiber is used in the G-end medical and beauty care fields. In the future, Yongxin Technology will seize the huge demand for medical and health materials from the "two-child policy" and "aging society," continue to increase investment in R&D of G-end medical and health materials, keep optimizing and strengthening the industry, and lead industry development.